(Q53254184)

English

Fragmentation pathways of oxygenated tetracyclic triterpenoids and their application in the qualitative analysis of Ganoderma lucidum by multistage tandem mass spectrometry.

scientific article published in May 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21491533

Fragmentation pathways of oxygenated tetracyclic triterpenoids and their application in the qualitative analysis of Ganoderma lucidum by multistage tandem mass spectrometry. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21491533

Ganoderma lucidum

1 reference

ganoderic acid a

1 reference

1 reference

(5R,10S,13R,14R,17R)-17-[(2R,5S)-5,6-dihydroxy-6-methylheptan-2-yl]-4,4,10,13,14-pentamethyl-1,2,5,6,12,15,16,17-octahydrocyclopenta[a]phenanthren-3-one

1 reference

Ganoderic Acid B Methyl Ester

1 reference

(E,2S)-6-[(5R,7S,10S,13R,14R,15S,17R)-7,15-dihydroxy-4,4,10,13,14-pentamethyl-3,11-dioxo-2,5,6,7,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxohept-5-enoic acid

1 reference

3,7-Dioxo-24-desisopropyl-5alpha-lanosta-8-ene-24-oic acid

1 reference

(4S)-4-[(5R,7R,10S,13R,14R,17R)-7-hydroxy-4,4,10,13,14-pentamethyl-3,11,15-trioxo-1,2,5,6,7,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid

1 reference

(3S,5R,10S,13R,14R,17R)-17-[(2R,5S)-5,6-Dihydroxy-6-methylheptan-2-yl]-3-hydroxy-4,4,10,13,14-pentamethyl-1,2,3,5,6,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-7-one

1 reference

6-(3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-methylhept-2-enoic acid

1 reference

(E,2S)-2-methyl-4-oxo-6-[(3S,5R,7S,10S,13R,14R,15S,17R)-3,7,15-trihydroxy-4,4,10,13,14-pentamethyl-11-oxo-1,2,3,5,6,7,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]hept-5-enoic acid

1 reference

(2R,6R)-6-[(3S,5R,10S,12S,13R,14R,17R)-12-acetyloxy-3-hydroxy-4,4,10,13,14-pentamethyl-7,11,15-trioxo-1,2,3,5,6,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid

1 reference

Ganolucidic acid E

1 reference

(E,2S)-6-[(5R,7S,10S,13R,14R,17R)-7-hydroxy-4,4,10,13,14-pentamethyl-3,11,15-trioxo-1,2,5,6,7,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxohept-5-enoic acid

1 reference

(E,2S)-2-methyl-4-oxo-6-[(5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-3,7,11,15-tetraoxo-2,5,6,12,16,17-hexahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-5-enoic acid

1 reference

(2R,6R)-6-[(3S,5R,10S,12S,13R,14R,17R)-3,12-dihydroxy-4,4,10,13,14-pentamethyl-7,11,15-trioxo-1,2,3,5,6,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid

1 reference

(5R,10S,13R,14R,17R)-17-[(2S,5S)-5,6-dihydroxy-6-methylheptan-2-yl]-4,4,10,13,14-pentamethyl-2,5,6,11,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthrene-3,7-dione

1 reference

Ganoderic acid DM

1 reference

(2R,6R)-6-[(5R,10S,12S,13R,14R,17R)-12-acetyloxy-4,4,10,13,14-pentamethyl-3,7,11,15-tetraoxo-2,5,6,12,16,17-hexahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid

1 reference

(3S,5R,10S,13R,14R,17R)-3-hydroxy-17-[(E,2S)-7-hydroxy-6-methylhept-5-en-2-yl]-4,4,10,13,14-pentamethyl-1,2,3,5,6,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-7-one

1 reference

(2R,6R)-6-[(3S,5R,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-7,11,15-trioxo-1,2,3,5,6,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid

1 reference

15-Hydroxy-3,11,23-trioxolanost-8-en-26-oic acid

1 reference

(E,2S)-6-[(3S,5R,7S,10S,13R,14R,17R)-3,7-dihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxohept-5-enoic acid

1 reference

(3S,5R,10S,13R,14R,17R)-3-hydroxy-17-[(2S)-7-hydroxy-6-methylhept-5-en-2-yl]-4,4,10,13,14-pentamethyl-1,2,3,5,6,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-7-one

1 reference

(2R,6R)-2-methyl-4-oxo-6-[(3S,5R,7S,10S,12S,13R,14R,17R)-3,7,12-trihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]heptanoic acid

1 reference

ganoderic acid b

1 reference

methyl (2R,6R)-6-[(3S,5R,10S,12S,13R,14R,17R)-12-acetyloxy-3-hydroxy-4,4,10,13,14-pentamethyl-7,11,15-trioxo-1,2,3,5,6,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoate

1 reference

Ganoderic acid C1

1 reference

1 reference

1 reference

12b-Acetoxy-3b-hydroxy-4,4,14-trimethyl-7,11,15-trioxochol-8-en-24-oic acid, 9CI

1 reference

author name string

Chun-Ru Cheng

1

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21491533

Min Yang

2

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21491533

Zhi-Yuan Wu

3

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21491533

Yang Wang

4

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21491533

Feng Zeng

5

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21491533

Wan-Ying Wu

6

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21491533

Shu-Hong Guan

7

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21491533

De-An Guo

8

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21491533

publication date

13 April 2011

1 reference

16 September 2022

Rapid Communications in Mass Spectrometry

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21491533

25

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21491533

9

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21491533

1323-1335

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21491533

Anticancer Effects of Ganoderma lucidum: A Review of Scientific Evidence

1 reference

https://api.crossref.org/works/10.1002%2FRCM.4989

21 January 2018

Proteomics characterization of the cytotoxicity mechanism of ganoderic acid D and computer-automated estimation of the possible drug target network

1 reference

https://api.crossref.org/works/10.1002%2FRCM.4989

21 January 2018

Inhibition of cytopathic effect of human immunodeficiency virus-1 by water-soluble extract ofGanoderma lucidum

1 reference

https://api.crossref.org/works/10.1002%2FRCM.4989

21 January 2018

Evaluation of the hepatic and renal-protective effects of Ganoderma lucidum in mice

1 reference

https://api.crossref.org/works/10.1002%2FRCM.4989

21 January 2018

Ganoderma lucidum and its pharmaceutically active compounds

1 reference

https://api.crossref.org/works/10.1002%2FRCM.4989

21 January 2018

Phytochemical analysis of traditional Chinese medicine using liquid chromatography coupled with mass spectrometry

1 reference

https://api.crossref.org/works/10.1002%2FRCM.4989

21 January 2018

Basic rules for the interpretation of atmospheric pressure ionization mass spectra of small molecules

1 reference

https://api.crossref.org/works/10.1002%2FRCM.4989

21 January 2018

Group-specific fragmentation of pesticides and related compounds in liquid chromatography-tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1002%2FRCM.4989

21 January 2018

MassBank: a public repository for sharing mass spectral data for life sciences

1 reference

https://api.crossref.org/works/10.1002%2FRCM.4989

21 January 2018

A strategy for identification of oligosaccharide structures using observational multistage mass spectral library

1 reference

https://api.crossref.org/works/10.1002%2FRCM.4989

21 January 2018

Towards a full reference library of MS(n) spectra. Testing of a library containing 3126 MS2 spectra of 1743 compounds

1 reference

https://api.crossref.org/works/10.1002%2FRCM.4989

21 January 2018

Development of a chromatographic fingerprint for the chloroform extracts of Ganoderma lucidum by HPLC and LC-MS.

1 reference

https://api.crossref.org/works/10.1002%2FRCM.4989

21 January 2018

Evaluation of antiproliferative activities and action mechanisms of extracts from two species of Ganoderma on tumor cell lines

1 reference

https://api.crossref.org/works/10.1002%2FRCM.4989

21 January 2018

Electrochemical processes in electrospray ionization mass spectrometry

1 reference

https://api.crossref.org/works/10.1002%2FRCM.4989

21 January 2018

Characterization of an exception to the 'even-electron rule' upon low-energy collision induced decomposition in negative ion electrospray tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1002%2FRCM.4989

21 January 2018

Recent developments in the application of liquid chromatography–tandem mass spectrometry for the determination of organic residues and contaminants

1 reference

https://api.crossref.org/works/10.1002%2FRCM.4989

21 January 2018

The ‘even-electron rule’

1 reference

https://api.crossref.org/works/10.1002%2FRCM.4989

21 January 2018

Advances in Techniques for Profiling Crude Extracts and for the Rapid Identificationof Natural Products: Dereplication, Quality Control and Metabolomics

1 reference

https://api.crossref.org/works/10.1002%2FRCM.4989

21 January 2018

Ganoderma lucidum in cancer research

1 reference

https://opencitations.net/index/api/v1/references/10.1002/RCM.4989

10 April 2024

Antimicrobial activity of Ganoderma lucidum extract alone and in combination with some antibiotics

1 reference

https://opencitations.net/index/api/v1/references/10.1002/RCM.4989

10 April 2024

Cytotoxic triterpenoids from Ganoderma lucidum

1 reference

https://opencitations.net/index/api/v1/references/10.1002/RCM.4989

10 April 2024

Analysis of triterpenoids in ganoderma lucidum using liquid chromatography coupled with electrospray ionization mass spectrometry

1 reference

https://opencitations.net/index/api/v1/references/10.1002/RCM.4989

10 April 2024

Identifiers

10.1002/RCM.4989

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21491533

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21491533

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53254184&oldid=2129516168"